JUN and non-alcoholic fatty liver: In order to analyse the expression of c-Jun at various stages of metabolic liver disease, immunohistochemistry was performed on liver sections from individuals without liver disease (n = 5) and patients with NAFL (i.e., steatosis) (n = 9) or NASH (n = 27).